Photonz Corporation Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Photonz Corporation General Information
Description
Operator of a biotechnology company intended to address cardiovascular diseases. The company produces omega-3 fatty acid eicosapentaenoic acid (EPA) from its primary source, marine microalgae using proprietary fermentation technology, thereby providing pharmaceutical companies the critical ingredient required in medicinal foods and pharmaceutical products.
Contact Information
Primary Industry
Biotechnology
Primary Office
- P.O. Box 21219
- Henderson
- Auckland, 0650
- New Zealand
Photonz Corporation Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Apr-2018 | 00.000 | Completed | Out of Business | ||
| 3. Angel (individual) | 01-Aug-2011 | 00.000 | Completed | Startup | ||
| 2. Grant | 28-Mar-2011 | $2.15M | $2.19M | Completed | Startup | |
| 1. Early Stage VC | $2.19M | $2.19M | Completed | Startup |
Photonz Corporation Patents
Photonz Corporation Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2011318683-A1 | Method of provision of silicate to culture media | Inactive | 22-Oct-2010 | 00000000 | |
| EP-2629882-A1 | Method of provision of silicate to culture media | Inactive | 22-Oct-2010 | 00000000 | |
| US-20130273637-A1 | Method of provision of silicate to culture media | Inactive | 22-Oct-2010 | 00000000 | |
| AU-2011312987-A1 | Heterotrophic microbial production of xanthophyll pigments | Inactive | 06-Oct-2010 | 000000000 | |
| US-20130309719-A1 | Heterotrophic microbial production of xanthophyll pigments | Inactive | 06-Oct-2010 | C12P23/00 |